Dr. Esteban N. Gurzov, a talented young scientist from Brussels, Belgium, was recently named the first recipient of JDRF’s Dr. Robert Goldstein Award.
This award is presented to a promising investigator in the field of type 1 diabetes research (T1D). It was established in 2018 in honour of the late Dr. Robert Goldstein who played a pivotal role in developing JDRF’s Research Department and who served as chief scientific officer for JDRF International and JDRF Canada for over two decades.
Dr. Gurzov has dedicated his career to investigating the origins of diabetes and obesity and the discovery of new treatment options. After his productive postdoctoral period in Belgium, he moved to Australia to continue his training in the biology of diabetes. In 2013, he established his own group at St. Vincent’s Institute of Medical Research in Melbourne. Four years later he received an associate researcher position to head the Signal Transduction and Metabolism laboratory at the ULB Center for Diabetes Research in Brussels.
Dr. Gurzov has since expanded his expertise to beta cell identity and function, and continues to demonstrate a high level of productivity and generate important contributions to the field of beta cell biology. His current research explores a class of enzymes called protein tyrosine phosphatases (PTPs) as novel therapeutic targets for beta cell survival.
Dr. Gurzov’s publication track record, growing integration into the T1D research community and success as an independent junior investigator suggest that he will become a key T1D academic scientist. An extraordinary addition to the JDRF family, he will ensure that the legacy of Dr. Goldstein lives on.